Table 1.
Comparisons in the patient and ocular characteristics in acute CRAO eyes between those not demonstrating and those demonstrating the mid-phase pinpoint hyperfluorescent spots on FFA at presentation
| CRAO eyes without MPHS (n = 12) |
CRAO eyes with MPHS (n = 11) |
P value | |
|---|---|---|---|
| Age (Median, IQR) [years] | 52.5 (48–70.5) | 41 (33–55) | 0.062 |
| Gender (Males) (n, %) | 9 (75) | 8 (73) | > 0.999 |
| Visual acuity range | LP negative – 6/60 | LP positive – 6/18 | |
| Duration of symptoms (days) | 5.583 ± 1.775 | 2.182 ± 1.093 | 0.075 |
| Presence of cilioretinal artery (n, %) | 6 (50) | 5 (45) | > 0.999 |
| Mild CRAO (n, %) | 3 (25) | 1 (9) | 0.59 |
| Moderate CRAO (n, %) | 4 (33) | 7 (64) | 0.22 |
| Severe CRAO (n, %) | 5 (42) | 3 (27) | 0.67 |
| ART (seconds) | 29.96 ± 11.06 | 21.76 ± 9.25 | 0.062 |
Abbreviations: CRAO – central retinal artery occlusion; FFA – fundus fluorescein angiography; MPHS – mid-phase pinpoint hyperfluorescent spots; LP – light perception; IQR – interquartile range; ART – arm-retina time